Home Blog Page 118

Blog

Pharma Marketing Blog

Most popular

What Criteria Determine Substantive Pharma Influence Over Content on Social Media...

Pharma Guy - October 3, 2009

Free Samples: The Drug Rep’s Last Great Hope

Pharma Guy - October 22, 2008

Blame the Doc, Not DTC!

Pharma Guy - April 28, 2005

Missing FDA Letters Found. More Questions.

Pharma Guy - June 12, 2009

Awards. What Are They Good For?

Pharma Guy - October 29, 2007

Can an In-home Electronic Pillbox Solve Our Medication Error Problem?

Pharma Guy - June 22, 2007

Pay-(FDA)-Per-(Pre)View of DTC

Pharma Guy - September 1, 2006

A Snarky Look at Sneaky Marketing Tactics Pharma Hasn’t Avoided

Pharma Guy - February 18, 2010

Is Online Pharma Promotion ROI Scalable?

Pharma Guy - October 17, 2012

AstraZeneca’s Risky Proposition

Pharma Guy - November 17, 2005

1...117118119...240 Page 118 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026